share_log

Argus Research Maintains Buy on Moderna, Raises Price Target to $230

Argus Research Maintains Buy on Moderna, Raises Price Target to $230

Argus Research维持现代买入,将目标价上调至230美元
Benzinga Real-time News ·  2021/06/24 08:47

Argus Research analyst Jasper Hellweg maintains Moderna (NASDAQ:MRNA) with a Buy and raises the price target from $200 to $230.

Argus Research分析师Jasper Hellweg维持现代(纳斯达克股票代码:mRNA)的买入,并将目标价从200美元上调至230美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发